Anaphylaxis due to oral melphalan
Lawrence, B.V.
Cancer Treatment Reports 64(4-5): 731-732
1980
ISSN/ISBN: 0361-5960 PMID: 7427957 Document Number: 159769
Document emailed within 1 workday
Related Documents
Milliken, S.; Powles, R.; Jones, A.; Helenglass, G. 1989: Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan Transplantation Proceedings 21(1 Pt 3): 3067Ghosh, J.B. 1995: Anaphylaxis following oral cotrimoxazole Indian Pediatrics 32(7): 827
Hall, A.G.; Matheson, E.; Hickson, I.D.; Foster, S.A.; Hogarth, L. 1994: Purification of an alpha class glutathione S-transferase from melphalan-resistant Chinese hamster ovary cells and demonstration of its ability to catalyze melphalan-glutathione adduct formation Cancer Research 54(13): 3369-3372
Kusunoki, T.; Mukaida, K.; Hayashi, A.; Nozaki, F.; Hiejima, I.; Kumada, T.; Miyajima, T.; Fujii, T. 2014: A case of wheat-dependent exercise-induced anaphylaxis after specific oral immunotherapy Journal of Investigational Allergology and Clinical Immunology 24(5): 358-359
Barrera, O.M.; Murgas, I.L.; Bermúdez, S.; Miranda, R.J. 2015: Oral anaphylaxis by ingestion of mite contaminated food in Panama City, 2011-2014 Revista Alergia Mexico 62(2): 112-117
Mangodt, E.A.; Van Gasse, A.L.; Bridts, C.H.; Sabato, V.; Ebo, D.G. 2015: Simultaneous oral mite anaphylaxis (pancake syndrome) in a father and daughter and a review of the literature Journal of Investigational Allergology and Clinical Immunology 25(1): 75-76
Vistica, D.T.; Rabon, A.; Rabinovitz, M. 1979: Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells Research Communications in Chemical Pathology and Pharmacology 23(1): 171-183
Belasco, J.B.; Mitchell, C.D.; Rohrbaugh, T.; Rosenstock, J. 1987: IV melphalan in children Cancer Treatment Reports 71(12): 1277-1278
Vistica, D.T.; Rabon, A.; Rabinovitz, M. 1978: Enhancement of melphalan therapy with glutaminase:asparaginase Research Communications in Chemical Pathology and Pharmacology 22(1): 83-92
Braun, H.J. 1973: Intermittent tosstherapy of plasmacytoma with melphalan and predniso(lo)ne Minerva Medica 64(14): 679-682
Besses, C. 2001: 40 years ago in Medicina Clinica. The introduction of melphalan in Spain Medicina Clinica 117(1): 24-26
Kroon, B.B.; Van Geel, A.N.; Benckhuijsen, C.; Wieberdink, J. 1987: Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs Anticancer Research 7(3 Part B): 441-442
Levin, M.; Chokas, W. 1987: Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone New England Journal of Medicine 317(18): 1155-1156
Alexanian, R.; Migliore, P.J. 1970: Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy Journal of Laboratory and Clinical Medicine 75(2): 225-233
Takahashi, I.; Ohmoto, E.; Nakada, H.; Inagaki, N.; Nonaka, K.; Takeuchi, M.; Osada, K.; Tsurumi, N.; Uchida, K.; Yorimitsu, S. 1988: Clinical effects of K-18 (IgG-melphalan) in hypoplastic leukemia: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 159-162
de Castiglione, R.; Gozzini, L.; Galantino, M.; Corradi, F.; Arlandini, E.; Molinari, I.; Ciomei, M. 1991: Bombesin receptor antagonists. 3. Irreversible alkylating analogues: melphalan derivatives Farmaco 46(6): 743-757
Medina, D. 1977: Enhancement of mammary tumor formation in mice by a cytostatic drug, melphalan Cancer Research 37(1): 317-319
Kergueris, M.F.; Milpied, N.; Moreau, P.; Harousseau, J.L.; Larousse, C. 1994: Pharmacokinetics of high-dose melphalan in adults: influence of renal function Anticancer Research 14(6a): 2379-2382
Teicher, B.A.; Crawford, J.M.; Holden, S.A.; Cathcart, K.N. 1987: Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity Cancer Research 47(19): 5036-5041
Kvols, L.K.; Eagan, R.T.; Myers, R.P. 1977: Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report Cancer Treatment Reports 61(2): 311-312